Govindappa, Nagaraj,Sastry, Kedamath,Soares, Maria Melina
申请号：
AU2018202982
公开号：
AU2018202982B2
申请日:
2018.04.30
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2018202982B220190822.pdf#####ABSTRACT The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of AntiEGFR1-TGFORII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
